dc.contributor.author | Organisation mondiale de la Santé | |
dc.coverage.spatial | Genève | EN |
dc.date.accessioned | 2014-12-18T08:38:34Z | |
dc.date.available | 2014-12-18T08:38:34Z | |
dc.date.issued | 2014 | |
dc.identifier.govdoc | WHO/HTM/TB/2014.1 | |
dc.identifier.isbn | 9789242506709 | |
dc.identifier.uri | https://iris.who.int/handle/10665/145682 | |
dc.description | 49 p. | EN |
dc.language.iso | en | EN |
dc.language.iso | fr | EN |
dc.language.iso | ru | EN |
dc.publisher | Organisation mondiale de la Santé | EN |
dc.subject.mesh | Tuberculosis, Multidrug-Resistant | EN |
dc.subject.mesh | Tuberculosis | EN |
dc.subject.mesh | Rifampin | EN |
dc.subject.mesh | Mycobacterium tuberculosis | EN |
dc.subject.mesh | HIV Infections | EN |
dc.subject.mesh | Sensitivity and Specificity | EN |
dc.subject.mesh | Handbook | EN |
dc.title | Manuel de mise en oeuvre du test Xpert MTB/RIF : guide technique et opérationnel : considérations pratiques | EN |
dc.type | Publications | EN |
dc.subject.meshqualifier | diagnosis | EN |
dc.subject.meshqualifier | pharmacology | EN |
dc.subject.meshqualifier | isolation and purification | EN |
who.relation.languageVersion | 10665/112469 | EN |